The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?
Open accessAbstract
The concept of antimicrobial peptides (AMPs) as potent pharmaceuticals is firmly established in the literature, and most research articles on this topic conclude by stating that AMPs represent promising therapeutic agents against bacterial and fungal agents. Indeed, early research in this field showed that AMPs were diverse in nature, had high activities with low minimal inhibitory concentrations, had broad spectrums of activity against bacterial, fungal and viral pathogens, and could easily be manipulated to alter their specificities, reduce their cytotoxicities and increase their antimicrobial activities. Unfortunately, commercial development of these peptides, for even the simplest of applications, has been very limited. With some peptides there are obstacles with their manufacture, in vivo efficacy and in vivo retention. More recently, the focus has shifted. Contemporary research now uses a more sophisticated approach to develop AMPs that surmount many of these prior obstacles. AMP mimetics, hybrid AMPs, AMP congeners, cyclotides and stabilised AMPs, AMP conjugates and immobilised AMPs have all emerged with selective or ‘targeted’ antimicrobial activities, improved retention, or unique abilities that allow them to bind to medical or industrial surfaces. These groups of new peptides have creative medical and industrial application potentials to treat antibiotic-resistant bacterial infections and septic shock, to preserve food or to sanitise surfaces both in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Self-citationAntimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Futaki, S., Suzuki, T., Ohashi, W., Yagami, T., Tanaka, S., Ueda, K., & Sugiura, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007540200 · Cited by 1,662
Mammalian defensins in the antimicrobial immune response
Selsted, M. E., & Ouellette, A. J. (2005) · Nature Immunology · doi:10.1038/ni1206 · Cited by 1,203
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces
Costa, F., Carvalho, I. F., Montelaro, R. C., Gomes, P., & Martins, M. C. L. (2011) · Acta Biomaterialia · doi:10.1016/j.actbio.2010.11.005 · Cited by 627
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572 · cited 1×
“This is particularly true for defensins, which have direct antimicrobial activity, chemoattract phagocytic and mast cells, induce inflammatory mediators, regulate the functions of phagocytes, and regulate the complement system [5,6].”
BackgroundTam, J. P., Lu, Y.-A., Yang, J.-L., & Chiu, K.-W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.8913 · Cited by 487
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1
Schroeder, B. O., Wu, Z., Nuding, S., Groscurth, S., Marcinowski, M., Beisner, J., Buchner, J., Schaller, M., Stange, E. F., & Wehkamp, J. (2011) · Nature · doi:10.1038/nature09674 · Cited by 457
Lehrer, R. I. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro976 · Cited by 448
Wu, Z., Hoover, D. M., Yang, D., Boulègue, C., Santamaria, F., Oppenheim, J. J., Lubkowski, J., & Lu, W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533186100 · Cited by 439
Gao, G., Lange, D., Hilpert, K., Kindrachuk, J., Zou, Y., Cheng, J. T. J., Kazemzadeh-Narbat, M., Yu, K., Wang, R., Straus, S. K., et al. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.02.013 · Cited by 388
Bactericidal Activity of Mammalian Cathelicidin-Derived Peptides
Travis, S. M., Anderson, N. N., Forsyth, W. R., Espiritu, C., Conway, B. D., Greenberg, E. P., McCray, P. B., Lehrer, R. I., Welsh, M. J., & Tack, B. F. (2000) · Infection and Immunity · doi:10.1128/iai.68.5.2748-2755.2000 · Cited by 369
A Re-evaluation of the Role of Host Defence Peptides in Mammalian Immunity
Bowdish, D., Davidson, D., & Hancock, R. (2005) · Current Protein & Peptide Science · doi:10.2174/1389203053027494 · Cited by 368
Clinical Development of Cationic Antimicrobial Peptides: From Natural to Novel Antibiotics
Hancock, R., & Patrzykat, A. (2002) · Current Drug Target -Infectious Disorders · doi:10.2174/1568005024605855 · Cited by 365
Takahashi, D., Shukla, S. K., Prakash, O., & Zhang, G. (2010) · Biochimie · doi:10.1016/j.biochi.2010.02.023 · Cited by 331
Tethering antimicrobial peptides: Current status and potential challenges
Onaizi, S. A., & Leong, S. S. J. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.08.012 · Cited by 305
Findlay, B., Zhanel, G. G., & Schweizer, F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00530-10 · Cited by 301
Natural roles of antimicrobial peptides in microbes, plants and animals
Maróti, G., Kereszt, A., Kondorosi, É., & Mergaert, P. (2011) · Research in Microbiology · doi:10.1016/j.resmic.2011.02.005 · Cited by 298
Binding and action of cecropin and cecropin analogues: Antibacterial peptides from insects
Steiner, H., Andreu, D., & Merrifield, R. B. (1988) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(88)90069-7 · Cited by 298
Antimicrobial peptide mimics for improved therapeutic properties
Rotem, S., & Mor, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.020 · Cited by 296
Biragyn, A., Surenhu, M., Yang, D., Ruffini, P. A., Haines, B. A., Klyushnenkova, E., Oppenheim, J. J., & Kwak, L. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6644 · Cited by 286
Structural determinants of antimicrobial activity in polymers which mimic host defense peptides
Palermo, E. F., & Kuroda, K. (2010) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-010-2687-z · Cited by 281
Improved antimicrobial peptides based on acyl-lysine oligomers
Radzishevsky, I. S., Rotem, S., Bourdetsky, D., Navon-Venezia, S., Carmeli, Y., & Mor, A. (2007) · Nature Biotechnology · doi:10.1038/nbt1309 · Cited by 256
Antimicrobial Characterization of Human β-Defensin 3 Derivatives
Hoover, D. M., Wu, Z., Tucker, K., Lu, W., & Lubkowski, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2804-2809.2003 · Cited by 253
Antibacterial and Antifouling Polymer Brushes Incorporating Antimicrobial Peptide
Glinel, K., Jonas, A. M., Jouenne, T., Leprince, J., Galas, L., & Huck, W. T. S. (2009) · Bioconjugate Chemistry · doi:10.1021/bc800280u · Cited by 248
Host defense peptides and their antimicrobial-immunomodulatory duality
Steinstraesser, L., Kraneburg, U., Jacobsen, F., & Al-Benna, S. (2011) · Immunobiology · doi:10.1016/j.imbio.2010.07.003 · Cited by 247
Ciornei, C. D., Sigurdardóttir, T., Schmidtchen, A., & Bodelsson, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2845-2850.2005 · Cited by 247
Osusky, M., Zhou, G., Osuska, L., Hancock, R. E., Kay, W. W., & Misra, S. (2000) · Nature Biotechnology · doi:10.1038/81145 · Cited by 246
Targeted Killing of Streptococcus mutans by a Pheromone-Guided “Smart” Antimicrobial Peptide
Eckert, R., He, J., Yarbrough, D. K., Qi, F., Anderson, M. H., & Shi, W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00622-06 · Cited by 238
Bagheri, M., Beyermann, M., & Dathe, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01254-08 · Cited by 238
Prokaryotic Antimicrobial Peptides
Jong, D. A., van Heel, A., & Kuipers, O. P. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7692-5 · Cited by 231
Luckarift, H. R., Dickerson, M. B., Sandhage, K. H., & Spain, J. C. (2006) · Small · doi:10.1002/smll.200500376 · Cited by 227
Kichler, A., Leborgne, C., März, J., Danos, O., & Bechinger, B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0337677100 · Cited by 226
Etienne, O., Picart, C., Taddei, C., Haikel, Y., Dimarcq, J. L., Schaaf, P., Voegel, J. C., Ogier, J. A., & Egles, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3662-3669.2004 · Cited by 209
SMAP‐29: a potent antibacterial and antifungal peptide from sheep leukocytes
Skerlavaj, B., Benincasa, M., Risso, A., Zanetti, M., & Gennaro, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01600-2 · Cited by 205
Antibacterial peptides and proteins with multiple cellular targets
Otvos, L. J. (2005) · Journal of Peptide Science · doi:10.1002/psc.698 · Cited by 178
Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin
Haynie, S. L., Crum, G. A., & Doele, B. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.2.301 · Cited by 178
Antimicrobial Peptides for Detection of Bacteria in Biosensor Assays
Kulagina, N. V., Lassman, M. E., Ligler, F. S., & Taitt, C. R. (2005) · Analytical Chemistry · doi:10.1021/ac050639r · Cited by 175
Structural Requirements of Lipid a for Endotoxicity and Other Biological Activities
Takada, H., Kotani, S., & Luderitz, O. (1989) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418909104475 · Cited by 168
Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria
Piers, K. L., Brown, M. H., & Hancock, R. E. W. (1993) · Gene · doi:10.1016/0378-1119(93)90168-3 · Cited by 167
Piers, K. L., Brown, M. H., & Hancock, R. E. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.10.2311 · Cited by 167
Kluskens, L., Nelemans, S. A., Rink, R., de Vries, L., Meter-Arkema, A. H., Wang, Y., Walther, T., Kuipers, A., Moll, G. N., & Haas, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146431 · Cited by 165
Lienkamp, K., & Tew, G. N. (2009) · Chemistry – A European Journal · doi:10.1002/chem.200900049 · Cited by 159
Peschen, D., Li, H., Fischer, R., Kreuzaler, F., & Liao, Y. (2004) · Nature Biotechnology · doi:10.1038/nbt970 · Cited by 144
A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity.
Larrick, J. W., Hirata, M., Zheng, H., Zhong, J., Bolin, D., Cavaillon, J., Warren, H. S., & Wright, S. C. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.231 · Cited by 142
Guyomard-Lack, A., Dé, E., Jouenne, T., Malandain, J., Müller, G., & Glinel, K. (2008) · Advanced Functional Materials · doi:10.1002/adfm.200700793 · Cited by 139
Optimized grafting of antimicrobial peptides on stainless steel surface and biofilm resistance tests
Héquet, A., Humblot, V., Berjeaud, J., & Pradier, C. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.01.012 · Cited by 135
Design of Synthetic Antimicrobial Peptides Based on Sequence Analogy and Amphipathicity
Tossi, A., Tarantino, C., & Romeo, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0549a.x · Cited by 133
Incorporation of antimicrobial compounds in mesoporous silica film monolith
Izquierdo‐Barba, I., Vallet‐Regí, M., Kupferschmidt, N., Terasaki, O., Schmidtchen, A., & Malmsten, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.003 · Cited by 133
Saiman, L. M., Tabibi, S., Starner, T. D., Gabriel, P. S., Winokur, P. L., Jia, H. P., McCray, P. B., & Tack, B. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2838-2844.2001 · Cited by 127
Cutter, C. N., Willett, J. L., & Siragusa, G. R. (2001) · Letters in Applied Microbiology · doi:10.1046/j.1472-765x.2001.01005.x · Cited by 124
Cathelicidins and functional analogues as antisepsis molecules
Mookherjee, N., Rehaume, L. M., & Hancock, R. E. W. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.8.993 · Cited by 121
Chain length dependence of antimicrobial peptide–fatty acid conjugate activity
Chu-Kung, A. F., Nguyen, R., Bozzelli, K. N., & Tirrell, M. (2009) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2009.11.057 · Cited by 120
Yoshinari, M., Kato, T., Matsuzaka, K., Hayakawa, T., & Shiba, K. (2009) · Biofouling · doi:10.1080/08927010903216572 · Cited by 112
Advances in Peptide Pharmaceuticals
Stevenson, C. L. (2009) · Current Pharmaceutical Biotechnology · doi:10.2174/138920109787048634 · Cited by 111
Antimicrobial peptide-based array for Escherichia coli and Salmonella screening
Kulagina, N. V., Shaffer, K. M., Anderson, G. P., Ligler, F. S., & Taitt, C. R. (2006) · Analytica Chimica Acta · doi:10.1016/j.aca.2006.05.082 · Cited by 110
Krishnakumari, V., Rangaraj, N., & Nagaraj, R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00470-08 · Cited by 110
Efficacy of Antimicrobial Peptoids against Mycobacterium tuberculosis
Kapoor, R., Eimerman, P. R., Hardy, J. W., Cirillo, J. D., Contag, C. H., & Barron, A. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01667-10 · Cited by 106
Scudiero, O., Galdiero, S., Cantisani, M., Noto, R. D., Vitiello, M., Galdiero, M., Naclerio, G., Cassiman, J., Pedone, C., Castaldo, G., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01550-09 · Cited by 105
cDNA sequences of three sheep myeloid cathelicidins
Bagella, L., Scocchi, M., & Zanetti, M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01285-3 · Cited by 103
Taylor, K. J., Clarke, D. J., McCullough, B. J., Chin, W., Seo, E. S., Yang, D., Oppenheim, J. J., Uhrı́n, D., Govan, J. R. W., Campopiano, D. J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709238200 · Cited by 95
Brogden, K. A., Kalfa, V. C., Ackermann, M. R., Palmquist, D. E., McCray, P. B., & Tack, B. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.331-334.2001 · Cited by 95
Self-citationSawai, M. V., Waring, A. J., Kearney, W. R., McCray, P. B., Forsyth, W. R., Lehrer, R. I., & Tack, B. F. (2002) · Protein Engineering Design and Selection · doi:10.1093/protein/15.3.225 · Cited by 94
Yevtushenko, D. P., Romero, R., Forward, B. S., Hancock, R. E. W., Kay, W. W., & Misra, S. (2005) · Journal of Experimental Botany · doi:10.1093/jxb/eri165 · Cited by 93
Antimicrobial activity of rabbit CAP18-derived peptides
Larrick, J. W., Hirata, M., Shimomoura, Y., Yoshida, M., Zheng, H., Zhong, J., & Wright, S. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.12.2534 · Cited by 90
Qiu, X., Wang, H., Lu, X.-F., Zhang, J., Li, S., Cheng, G., Wan, L., Yang, L., Zuo, J.-Y., Zhou, Y., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt913 · Cited by 89
Characterization of a rabbit cationic protein (CAP18) with lipopolysaccharide-inhibitory activity
Hirata, M., Shimomura, Y., Yoshida, M., Morgan, J. G., Palings, I., Wilson, D., Yen, M. H., Wright, S. C., & Larrick, J. W. (1994) · Infection and Immunity · doi:10.1128/iai.62.4.1421-1426.1994 · Cited by 88
Liu, S., Zhou, L., Li, J., Suresh, A., Verma, C. S., Foo, Y. H., Yap, P. H., Tan, D. T. H., & Beuerman, R. W. (2008) · ChemBioChem · doi:10.1002/cbic.200700560 · Cited by 86
Congeners of SMAP29 Kill Ovine Pathogens and Induce Ultrastructural Damage in Bacterial Cells
Kalfa, V. C., Jia, H. P., Kunkle, R. A., McCray, P. B., Tack, B. F., & Brogden, K. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3256-3261.2001 · Cited by 86
Self-citationPiers, K. L., & Hancock, R. E. W. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01083.x · Cited by 85
Strategies for the Discovery and Advancement of Novel Cationic Antimicrobial Peptides
Hadley, E. B., & Hancock, R. E. W. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610793176648 · Cited by 83
Beta‐defensins: what are they REALLY doing in the oral cavity?
Diamond, G., & Ryan, L. K. (2011) · Oral Diseases · doi:10.1111/j.1601-0825.2011.01799.x · Cited by 82
Molecular analysis of the sheep cathelin family reveals a novel antimicrobial peptide
Mahoney, M. M., Lee, A. Y., Brezinski-Caliguri, D. J., & Huttner, K. M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01390-3 · Cited by 82
Craik, D. J., & Conibear, A. C. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo200520v · Cited by 80
Garcia, A., & Camarero, J. A. (2010) · Current Molecular Pharmacology · doi:10.2174/1874-470211003030153 · Cited by 78
Anti-microbial activity of human CAP18 peptides
Larrick, J. W., Hirata, M., Zhong, J., & Wright, S. C. (1995) · Immunotechnology · doi:10.1016/1380-2933(95)00006-2 · Cited by 78
Minimal antimicrobial peptidic sequence from hemoglobin alpha-chain: KYR
Catiau, L., Traisnel, J., Delval-Dubois, V., Chihib, N., Guillochon, D., & Nedjar‐Arroume, N. (2011) · Peptides · doi:10.1016/j.peptides.2010.12.016 · Cited by 78
Structural, functional analysis and localization of the human CAP18 gene
Larrick, J. W., Lee, J., Ma, S.-W., Li, X., Francke, U., Wright, S. C., & Balint, R. F. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01199-4 · Cited by 76
Bai, Y., Liu, S., Jiang, P., Zhou, L., Li, J., Tang, C., Verma, C. S., Mu, Y., Beuerman, R. W., & Pervushin, K. V. (2009) · Biochemistry · doi:10.1021/bi900670d · Cited by 74
Engineered Salt-insensitive α-Defensins with End-to-end Circularized Structures
Yu, Q., Lehrer, R. I., & Tam, J. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3943 · Cited by 69
Isolation, Sequencing, and Structure−Activity Relationships of Cyclotides
Ireland, D. C., Clark, R. J., Daly, N. L., & Craik, D. J. (2010) · Journal of Natural Products · doi:10.1021/np1000413 · Cited by 67
Design and activity of a ‘dual-targeted’ antimicrobial peptide
He, J. G., Anderson, M. H., Shi, W., & Eckert, R. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.11.013 · Cited by 65
Sawa, T., Kurahashi, K., Ohara, M., Gropper, M. A., Doshi, V., Larrick, J. W., & Wiener-Kronish, J. P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3269 · Cited by 63
Impact of Self-Assembly Properties on Antibacterial Activity of Short Acyl-Lysine Oligomers
Sarig, H., Rotem, S., Ziserman, L., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00656-08 · Cited by 61
Pasupuleti, M., Chalupka, A., Mörgelin, M., Schmidtchen, A., & Malmsten, M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.03.029 · Cited by 58
Adsorption behavior of antimicrobial peptide histatin 5 on PMMA
Yoshinari, M., Kato, T., Matsuzaka, K., Hayakawa, T., Inoue, T., Oda, Y., Okuda, K., & Shimono, M. (2005) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.30393 · Cited by 56
Jung, S., Mysliwy, J. H., Spudy, B., Lorenzen, I., Reiß, K., Gelhaus, C., Podschun, R., Leippe, M., & Grötzinger, J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00872-10 · Cited by 55
The Antibacterial Effect of a Proline-Rich Antibacterial Peptide A3-APO
Rozgonyi, F., Szabó, D., Kocsis, B., Ostorházi, E., Abbadessa, G., Cassone, M., Wade, J. D., & Otvos, L., Jr. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789352295 · Cited by 51
Synthetic Mimics of Antimicrobial Peptides from Triaryl Scaffolds
Thaker, H. D., Sgolastra, F., Clements, D. J., Scott, R. W., & Tew, G. N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101410t · Cited by 50
An, L., Yang, Y.-H., Ma, X., Lin, Y., Li, G., Song, Y., & Wu, K. (2005) · Leukemia Research · doi:10.1016/j.leukres.2004.11.009 · Cited by 42
Hua, J., Yamarthy, R., Felsenstein, S., Scott, R. W., Markowitz, K., & Diamond, G. (2010) · Molecular Oral Microbiology · doi:10.1111/j.2041-1014.2010.00590.x · Cited by 41
Qiu, X., Zhang, J., Wang, H., & Wu, G. Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.3.1184-1189.2005 · Cited by 41
Saravanan, R., Bhunia, A., & Bhattacharjya, S. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.07.014 · Cited by 40
Salvucci, E., Saavedra, L., & Sesma, F. J. M. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm096 · Cited by 38
Kohlgraf, K. G., Ackermann, A. R., Lu, X., Burnell, K. K., Bélanger, M., Cavanaugh, J. E., Xie, H., Progulske‐Fox, A., & Brogden, K. A. (2009) · Future Microbiology · doi:10.2217/fmb.09.107 · Cited by 32
Self-citationMathison, R. D., Davison, J. S., Befus, A. D., & Gingerich, D. A. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-49 · Cited by 32
Leupold, E., Nikolenko, H., & Dathe, M. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.11.025 · Cited by 27
Xiong, Y. Q., Bayer, A. S., Elazegui, L., & Yeaman, M. R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00038-06 · Cited by 25
Bucki, R., Leszczyńska, K., Byfield, F. J., Fein, D. E., Won, E., Cruz, K., Namiot, A., Kułakowska, A., Namiot, Z., Savage, P. B., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01682-09 · Cited by 25
Transdermal Delivery Enhanced by Antimicrobial Peptides
Kim, Y., Ludovice, P. J., & Prausnitz, M. R. (2010) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2010.1158 · Cited by 21
Weistroffer, P. L., Joly, S., Srikantha, R., Tack, B. F., Brogden, K. A., & Guthmiller, J. M. (2008) · Oral Microbiology and Immunology · doi:10.1111/j.1399-302x.2007.00389.x · Cited by 20
Self-citationExperimental Conditions That Enhance Potency of an Antibacterial Oligo-Acyl-Lysyl
Goldfeder, Y., Zaknoon, F., & Mor, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01656-09 · Cited by 20
Antibacterial Properties and Mode of Action of a Short Acyl-Lysyl Oligomer
Zaknoon, F., Sarig, H., Rotem, S., Livne, L., Ivankin, A., Gidalevitz, D., & Mor, A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00010-09 · Cited by 20
Design and Engineering Strategies for Synthetic Antimicrobial Peptides
Tossi, A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7692-5_6 · Cited by 13
Perspectives and Peptides of the Next Generation
Brogden, K. A. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7692-5_20 · Cited by 5
Self-citation
Cited by
Prevention of Intravascular Catheter-Related Infections
(2021) · Indian Journal of Continuing Nursing Education · doi:10.4103/2230-7354.320831 · Cited by 855
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 567
Gan, B. H., Gaynord, J., Rowe, S. M., Deingruber, T., & Spring, D. R. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00729c · Cited by 511
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 481
Combating Multidrug‐Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
O'Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209979 · Cited by 435
Metadata
- Authors
- Brogden, N. K., & Brogden, K. A.
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 38
- Issue
- 3
- Pages
- 217-25
- ISSN
- 0924-8579 (ISSN-L)
- OpenAlex
- W2151084977
- Cited by
- 300
- References
- 107
- FWCI
- 20.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.